A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-08-03) →
What happened
Penetrium Bioscience updated the terms of a new share issuance to raise US$22.3M, about 7.9% of its market value.
For context, this raise equals about 7.9% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Share issuance |
|---|---|
| Raise amount | US$22.3M |
| vs. market value | 7.9% |
| Filed | 2026-06-26, [Amended] Material event report (rights offering) |
| Source | DART rcept 20260626000207 → open original filing |
Versions of this filing
- 2026-04-30Original
- 2026-05-27Amendment 1
- 2026-06-11Amendment 2
- 2026-06-26Amendment 3 (this page)
- 2026-08-03Amendment 4
Source: DART. Information only, not investment advice.